GlassScriptPhysician profile
Kayla L Olson
NPI 1770968232
$6,222.13
in general payments reported to CMS, 2019-2025
13 companies · $2,706 in 2025
The $2,706 reported for 2025 was more than what 94% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $294 · 2022: $634 · 2023: $1,389 · 2024: $1,200 · 2025: $2,706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,648 · Food and Beverage: $2,647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,647.53 |
| Food and Beverage | $2,646.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,216.65 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Selectsecure |
| Abbott Laboratories | $2,026.38 | 2022-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Heartflow, INC. | $406.52 | 2024-2025 | |
| Edwards Lifesciences Corporation | $137.96 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $103.82 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $89.99 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $64.72 | 2024 | Wainua |
| Actelion Pharmaceuticals US, INC. | $56.62 | 2023 | Opsumit, Uptravi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.30 | 2024 | Lifevest |
| Teleflex LLC | $24.74 | 2024 | Guideliner |
| Lilly USA, LLC | $19.88 | 2025 | Zepbound |
| Scpharmaceuticals INC. | $19.84 | 2024 | |
| Boston Scientific Corporation | $13.71 | 2025 | Accolade Sr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.